News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
U.S. Warns Abraxis BioScience, Inc. About Plant Problems
February 16, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Feb 15 (Reuters) - U.S. regulators have warned Abraxis BioScience Inc. (ABBI.O: Quote, Profile , Research) about manufacturing problems at an Illinois plant, according to a letter released on Thursday.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
Real estate
Regulatory
MORE ON THIS TOPIC
Immunology and inflammation
AB Science ends 3 studies in multiple sclerosis, other immune conditions
July 13, 2026
·
2 min read
·
Tristan Manalac
Complete response letters
FDA posts new rejection letters days after confirming pause
July 13, 2026
·
1 min read
·
Tristan Manalac
Antibody-drug conjugates
GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
July 10, 2026
·
1 min read
·
Gabrielle Masson
Huntington’s disease
Roche scraps 2 Huntington’s studies, handing Ionis more bad news
July 10, 2026
·
2 min read
·
Tristan Manalac
